Premeal insulin treatment during basal-bolus regimen in young children with type 1 diabetes

Diabetes Care

Volumn 29, Issue 10, 2006, Pages 2311-2312

  Cherubini, Valentino ^a   Iannilli, Antonio ^a   Iafusco, Dario ^b   Cardella, Francesca ^c   Giamprini, Maria Sole ^a   Fanelli, Carmine ^d   Coppa, Giovanni Valentino ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN DERIVATIVE; INSULIN GLARGINE; ISOPHANE INSULIN; RECOMBINANT HUMAN INSULIN;

ARTICLE; CARBOHYDRATE ANALYSIS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FOOD INTAKE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; METABOLISM; POSTPRANDIAL STATE; PREPUBERTY; RANDOMIZED CONTROLLED TRIAL;

BLOOD GLUCOSE; CHILD; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; EATING; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN;

EID: 33845424577     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-0754     Document Type: Article

References (6)

1. Alemzadeh R, Berhe T, Wyatt DT: Flexible insulin therapy with glargine insulin improved glycemic control and reduced severe hypoglycemia among preschoolaged children with type 1 diabetes mellitus. Pediatrics 115:1320-1324, 2005
2. Jones SM, Quarry JL, Caldwell-McMillan M, Mauger DT, Gabbay RA: Optimal insulin pump dosing and postprandial glycemia following a pizza meal using the continuous glucose monitoring system. Diabetes Technol Ther 7:233-240, 2005
3. Lepore M, Pampanelli S, Fanelli C, Porcellati F, Bartocci L, Di Vincenzo A, Cordoni C, Costa E, Brunetti P, Bolli GB: Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 49:2142-2148, 2000
4. Colino E, López-Capapé M, Golmayo L, Álvarez MA, Alonso M, Barrio R: Therapy with insulin glargine (Lantus) in toddlers, children and adolescents with type 1 diabetes. Diabetes Res Clin Pract 70:1-7, 2005
5. Schober E, Schoenle E, Van Dyk J, Wernicke-Panten K, the Pediatric Study Group of Insulin Glargine: Comparative trial between insulin glargine and NPH insulin children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 15:369-376, 2002
6. Raskin P, Klaff L, Bergenstal R, Hallé JP, Donley D, Mecca T: A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes. Diabetes Care 23:1666-1671, 2000